Alphatec Holdings Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
14analysts covering
FY Revenue (est.)
$882.1Mnext fiscal year
FY EPS (est.)
$0.32next fiscal year
Monitoring Framework
Key Performance Indicators
Surgical Revenue Growth Quarterly1,700.0%Target: 17% growth for FY 2026 (~$805 million)
EOS Segment Revenue Quarterly14MTarget: ~$77 million for FY 2026
Adjusted EBITDA Margin Quarterly1,100.0%Target: 15% margin for FY 2026 (~$134 million)
Free Cash Flow Quarterly-11MTarget: At least $20 million for FY 2026
Watch Items
- EOS Segment Execution and Sales Force ProductivityTrigger: Continued quarterly revenue declines or failure to meet the revised $77 million annual targetAction: Re-evaluate commercial leadership, sales incentives, and downstream marketing support for the EOS imaging platform.
- Debt Leverage and Interest CoverageTrigger: Failure to realize the projected $6 million in annual interest savings from the new syndicated bank facilityAction: Review cash flow allocation, debt paydown schedules, and compliance with bank covenants under the JPMorgan-led facility.
Research as of 19 Jun 2026